Spotlight Medical Announces Publication in Journal of Clinical Oncology Validating AI ...
Current guidelines recommend adjuvant escalation with CDK4/6 inhibitors for clinically high- risk ER+/HER2− disease, yet no routinely available tool ...
Read the original at morningstar.com ↗
- Topics
- Healthcare
- Tracked via
- “AI Risks”